Price Action To Observe: CVS Health Corp Rises A lot Today, Is Now One of The Best Performer

Price Action To Observe: CVS Health Corp Rises A lot Today, Is Now One of The Best Performer

The stock of CVS Health Corp (NYSE:CVS) is a huge mover today! About 1.82M shares traded hands. CVS Health Corp (NYSE:CVS) has declined 14.05% since March 9, 2016 and is downtrending. It has underperformed by 21.46% the S&P500.
The move comes after 6 months positive chart setup for the $92.53B company. It was reported on Oct, 12 by We have $142.17 PT which if reached, will make NYSE:CVS worth $58.29 billion more.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on November, 4. They expect $1.57 earnings per share, up 22.66% or $0.29 from last year’s $1.28 per share. CVS’s profit will be $1.67 billion for 13.89 P/E if the $1.57 EPS becomes a reality. After $1.32 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 18.94% EPS growth.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Out of 15 analysts covering CVS Health (NYSE:CVS), 11 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. CVS Health has been the topic of 22 analyst reports since July 22, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating by Vetr given on Monday, August 24. The stock has “Overweight” rating given by Barclays Capital on Thursday, March 10. The rating was maintained by Mizuho on Thursday, June 23 with “Buy”. Oppenheimer maintained CVS Health Corp (NYSE:CVS) on Friday, August 28 with “Outperform” rating. The company was maintained on Wednesday, August 5 by RBC Capital Markets. The firm has “Buy” rating by Argus Research given on Monday, August 10. The stock of CVS Health Corp (NYSE:CVS) has “Equal-Weight” rating given on Monday, June 20 by Morgan Stanley. JP Morgan maintained CVS Health Corp (NYSE:CVS) rating on Monday, November 2. JP Morgan has “Overweight” rating and $123 price target. The rating was maintained by Deutsche Bank on Wednesday, July 22 with “Hold”. As per Thursday, August 20, the company rating was maintained by Deutsche Bank.

According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”

Insitutional Activity: The institutional sentiment decreased to 1 in 2016 Q2. Its down 0.10, from 1.1 in 2016Q1. The ratio worsened, as 67 funds sold all CVS Health Corp shares owned while 574 reduced positions. 97 funds bought stakes while 544 increased positions. They now own 833.68 million shares or 6.91% less from 895.55 million shares in 2016Q1.
Chatham Capital Grp has 0.15% invested in the company for 5,225 shares. Gideon reported 8,026 shares or 0.45% of all its holdings. The United Kingdom-based Legal And General Group Inc Public Ltd Com has invested 0.49% in CVS Health Corp (NYSE:CVS). Davenport & Company Lc owns 46,372 shares or 0% of their US portfolio. First Foundation Advsr last reported 2,723 shares in the company. Amp Cap Investors Ltd accumulated 0.57% or 907,731 shares. Matarin Cap Llc accumulated 0% or 49,526 shares. Mathes Inc owns 10,734 shares or 0.6% of their US portfolio. Harvest Capital Mgmt, a New Hampshire-based fund reported 5,195 shares. Cullen Frost Bankers Inc, a Texas-based fund reported 225,452 shares. Mai Capital has invested 0.7% of its portfolio in CVS Health Corp (NYSE:CVS). Horan Advsrs Lc holds 28,345 shares or 2.21% of its portfolio. Anderson Hoagland last reported 28,775 shares in the company. Glenmede Na holds 0.35% of its portfolio in CVS Health Corp (NYSE:CVS) for 598,159 shares. Moreover, Korea Invest has 0.63% invested in CVS Health Corp (NYSE:CVS) for 1.11M shares.

Insider Transactions: Since May 5, 2016, the stock had 0 insider purchases, and 3 insider sales for $5.83 million net activity. $4.02 million worth of CVS Health Corp (NYSE:CVS) was sold by MERLO LARRY J on Thursday, May 5. Another trade for 7,517 shares valued at $789,285 was sold by Brennan Troyen A. On Thursday, May 5 the insider GOLD STEPHEN J sold $1.03 million.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: which released: “Better Buy: CVS Health Corporation vs. Walgreens Boots Alliance” on October 11, 2016, also with their article: “Is CVS Health Creating Shareholder Value?” published on October 11, 2016, published: “CVS Health Slapped With Infringement Suit Over Heart Logo” on September 21, 2016. More interesting news about CVS Health Corp (NYSE:CVS) were released by: and their article: “Jim Cramer On CVS Health Corp And Skechers USA Inc” published on September 25, 2016 as well as‘s news article titled: “June 2017 Options Now Available For CVS Health (CVS)” with publication date: September 15, 2016.

CVS Company Profile

CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment